Search research articles
Contact Us
Filters
Showing results (71-80 of 116) with videos related to
Page
of 12
Sort By:
Ophthalmology
|
May 10, 2016
Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials
, Maureen G Maguire, Daniel F Martin, et al.
Ophthalmology
|
April 1, 2015
Influence of the Vitreomacular Interface on Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials
Thomas A Ciulla, Thomas A Cuilla, Gui-Shuang Ying, et al.
JAMA Ophthalmology
|
January 31, 2020
Characteristics of Eyes With Good Visual Acuity at 5 Years After Initiation of Treatment for Age-Related Macular Degeneration but Not Receiving Treatment From Years 3 to 5: Post Hoc Analysis of the CATT Randomized Clinical Trial
Drew Scoles, Gui-Shuang Ying, Wei Pan, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie
|
June 1, 2025
Association of changes in optical coherence tomography metrics with changes in refractive error in patients with neovascular age-related macular degeneration in the CATT
Matthew R Starr, Eric A Lovett, Rachel Israilevich, et al.
JCI Insight
|
November 2, 2023
A CD6-targeted antibody-drug conjugate as a potential therapy for T cell-mediated disorders
Lingjun Zhang, Liping Luo, Jin Y Chen, et al.
Ophthalmology Science
|
May 11, 2026
Diabetic Retinopathy Severity on Ultra-Widefield Fluorescein Angiography versus Color Photography and Association with Risk of Disease Worsening
Paolo S Silva, Danni Liu, Lloyd P Aiello, et al.
Ophthalmology. Retina
|
June 14, 2021
Predominantly Persistent Subretinal Fluid in the Comparison of Age-Related Macular Degeneration Treatments Trials
Jason Q Core, Maxwell Pistilli, Ebenezer Daniel, et al.
Ophthalmology
|
January 13, 2017
Incidence and Growth of Geographic Atrophy during 5 Years of Comparison of Age-Related Macular Degeneration Treatments Trials
Juan E Grunwald, Maxwell Pistilli, Ebenezer Daniel, et al.
Ophthalmology. Retina
|
April 11, 2022
Predominantly Persistent Intraretinal Fluid in the Comparison of Age-related Macular Degeneration Treatments Trials
Jason Q Core, Maxwell Pistilli, Peiying Hua, et al.
American Journal of Ophthalmology
|
November 22, 2020
Localized Optical Coherence Tomography Precursors of Macular Atrophy and Fibrotic Scar in the Comparison of Age-Related Macular Degeneration Treatments Trials
Avni P Finn, Maxwell Pistilli, Vincent Tai, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 116) with videos related to
Sort By:
Page
of 12
Ophthalmology
|
May 10, 2016
Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials
, Maureen G Maguire, Daniel F Martin, et al.
Ophthalmology
|
April 1, 2015
Influence of the Vitreomacular Interface on Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials
Thomas A Ciulla, Thomas A Cuilla, Gui-Shuang Ying, et al.
JAMA Ophthalmology
|
January 31, 2020
Characteristics of Eyes With Good Visual Acuity at 5 Years After Initiation of Treatment for Age-Related Macular Degeneration but Not Receiving Treatment From Years 3 to 5: Post Hoc Analysis of the CATT Randomized Clinical Trial
Drew Scoles, Gui-Shuang Ying, Wei Pan, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie
|
June 1, 2025
Association of changes in optical coherence tomography metrics with changes in refractive error in patients with neovascular age-related macular degeneration in the CATT
Matthew R Starr, Eric A Lovett, Rachel Israilevich, et al.
JCI Insight
|
November 2, 2023
A CD6-targeted antibody-drug conjugate as a potential therapy for T cell-mediated disorders
Lingjun Zhang, Liping Luo, Jin Y Chen, et al.
Ophthalmology Science
|
May 11, 2026
Diabetic Retinopathy Severity on Ultra-Widefield Fluorescein Angiography versus Color Photography and Association with Risk of Disease Worsening
Paolo S Silva, Danni Liu, Lloyd P Aiello, et al.
Ophthalmology. Retina
|
June 14, 2021
Predominantly Persistent Subretinal Fluid in the Comparison of Age-Related Macular Degeneration Treatments Trials
Jason Q Core, Maxwell Pistilli, Ebenezer Daniel, et al.
Ophthalmology
|
January 13, 2017
Incidence and Growth of Geographic Atrophy during 5 Years of Comparison of Age-Related Macular Degeneration Treatments Trials
Juan E Grunwald, Maxwell Pistilli, Ebenezer Daniel, et al.
Ophthalmology. Retina
|
April 11, 2022
Predominantly Persistent Intraretinal Fluid in the Comparison of Age-related Macular Degeneration Treatments Trials
Jason Q Core, Maxwell Pistilli, Peiying Hua, et al.
American Journal of Ophthalmology
|
November 22, 2020
Localized Optical Coherence Tomography Precursors of Macular Atrophy and Fibrotic Scar in the Comparison of Age-Related Macular Degeneration Treatments Trials
Avni P Finn, Maxwell Pistilli, Vincent Tai, et al.
Page
of 12